關於 Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210
成立時間2008
法律形式C Corporation
狀態營運中

評價

尚無評論。與 Ginkgo Bioworks Holdings, Inc. 合作過嗎?成為第一個分享經驗的人吧。

撰寫評論 →

關鍵數據

登入即可查看關鍵數據

Ginkgo Bioworks Holdings, Inc. 歷年的營收、淨利與員工人數,並附資料來源。

登入 使用電子郵件建立帳號

完全免費

地點

27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA 02210

這是你的公司嗎?

免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。

認領此頁面

分享這家公司

Ginkgo Bioworks Holdings, Inc.Biological Products, (No Diagnostic Substances)https://heelky.com/explore/companies/ginkgo-bioworks-holdings-inc-d5veyu2g/

複製連結

分享到

QR Code

用手機相機掃描即可開啟此頁面,也可以下載用於傳單、簡報或名牌。

加入 Heelky,建立人脈、招募人才、持續成長

建立免費帳號,即可傳送訊息、應徵職缺並發布任務。

立即加入 — 完全免費

選擇語言

Heelky 會記住你的選擇。

其他語言

可用語言:70 關於 Heelky 的語言